Diagnosis & Disease Information

Technique Clears Obstructed Ureters

WASHINGTON D.C.—The placement of transileal retrograde nephrostomy catheters (rPCN) is a safe and effective treatment for post-surgical ureteral obstruction following non-continent urinary diversion procedures, according to new data presented here at the 33rd Annual Scientific Meeting of the Society of Interventional Radiology (SIR).

High CRP Worsens Prognosis

Elevated C-reactive protein (CRP) levels before chemoradiotherapy for muscle-invasive bladder cancer is associated with a poor prognosis, according to researchers at Tokyo Medical and Dental University in Japan.

Manufacturing Issue Delays Restart of CIS Drug

Indevus Pharmaceuticals, Inc., of Lexington, Mass., has received a non-approvable letter from the FDA for Valstar (valrubicin solution), the only approved product for therapy of bacillus Calmette-Guérin-refractory carcinoma in situ of the urinary bladder.

TCC in Transplant Patients

Transitional cell carcinoma (TCC) is the predominant malignancy to develop in Chinese renal transplant recipients, according to researchers at the Capital University of Medical Sciences in Beijing.

Gemcitabine Prevents TCC Relapse

CHICAGO—Intravesical gemcitabine is an effective and well tolerated adjuvant local chemotherapy in patients with superficial bladder cancer, according to researchers in Algeria.

Next post in News